ARCHIVES

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

CTEP Deploys Website To Track Trial Activation

December 10, 2010

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

Smokers Quitlines Found Effective Regardless of Recruitment Method

June 24, 2011